TELESIS BIO (TBIO)
(Real Time Quote from BATS)
$3.75 USD
-0.05 (-1.32%)
Updated Jun 7, 2024 02:34 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[TBIO]
Reports for Purchase
Showing records 61 - 80 ( 108 total )
Industry: Medical - Drugs
Data From Cystic Fibrosis Therapy Delayed Due to COVID-19 Pandemic
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
COVID-19 Vaccine Manufacturing Scale Is Critical
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Phase 1/2 MRT5005 Data Anticipated 3Q20 as Pipeline and Collaboration Prospects Advance; Reit Buy and $18 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Drugs
Industry: Medical - Drugs
4Q19: CF Data in 3Q20 May Bring A Breath of Fresh Air
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Translating CF Know-How for Treating Lung Diseases May Not Be Far Fetched
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Spotlight on NACFC 2019: Hot Topics and Abstracts of Interest
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Drugs
Industry: Medical - Drugs
Translate To Present MRT5005 Cystic Fibrosis Data At The NACFC
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
OTC Program Termination Has No Read-Through To CF Program. Reiterate Buy.
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Thoughts Following MRT5005?s Early Efficacy Data; Reit Buy and $21PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A